A Basic Biochemical Approach to Addressing Chronic Kidney Disease
Plain-Language Summary
This published research paper, co-authored by Stephen McConnell, describes a combination of niacin, sodium bicarbonate, calcium carbonate, and isoquercetin used to address later-stage chronic kidney disease. The authors tracked kidney function markers in a group of patients over six months and report on the biochemical reasoning behind the approach, including its effect on phosphate levels, acidosis, and protein in the urine.
Key Concepts
- Co-authored by Stephen McConnell, W. Todd Penberthy, Richard Chern, and Chester H. Fox.
- Published in the Journal of Orthomolecular Medicine, Volume 40, Number 1.
- Describes a formulation combining niacin, sodium bicarbonate, calcium carbonate, and isoquercetin for CKD stages 3B–5.
- Tracks eGFR and urine albumin-creatinine ratio at baseline, 3 months, and 6 months across a documented patient cohort.
Stephen's Role
Co-Author
Citation
Penberthy, W. T., McConnell, S., Chern, R., & Fox, C. H. (2025). A basic biochemical approach to addressing chronic kidney disease. Journal of Orthomolecular Medicine, 40(1).
External Source
Journal of Orthomolecular Medicine, Vol. 40, No. 1→Educational Disclaimer
This entry is provided for educational purposes as part of the Research Library. See the Medical Disclaimer for full details.
If you found this article helpful, consider sharing it with a friend, family member, healthcare professional, or anyone interested in kidney health and ongoing research.